Validation of a commercially available anti-REDD1 antibody using RNA interference and REDD1-/- mouse embryonic fibroblasts

Deborah Grainger(Protein Technologies (United Kingdom)), Scot R. Kimball(Pennsylvania State University)
F1000Research
March 1, 2016
Cited by 4


Related Papers